Auger Radiation-Induced, Antisense-Mediated Cytotoxicity Of Tumor Cells Using A 3-Component Streptavidin-Delivery Nanoparticle With In-111

Xinrong Liu,Yi Wang,Kayoko Nakamura,Sumi Kawauchi,Ali Akalin,Dengfeng Cheng,Ling Chen,Mary Rusckowski,Donald J Hnatowich
DOI: https://doi.org/10.2967/jnumed.108.056366
2009-01-01
Journal of Nuclear Medicine
Abstract:When antisense oligomers are intracellular, they migrate to and are retained in the nucleus of tumor cells and therefore may be used to carry Auger electron-emitting radionuclides such as In-111 for effective tumor radiotherapy. Methods: Our nanoparticle consists of streptavidin that links 3 biotinylated components: the antiHer2 antibody trastuzumab (to improve pharmacokinetics), the tat peptide (to improve cell membrane transport), and the In-111-labeled antiRI alpha messenger RNA antisense morpholino (MORF) oligomer. Results: As evidence of unimpaired function, tumor cell and nuclear accumulations were orders of magnitude higher after incubation with Tc-99m-MORF/tat/trastuzumab than after incubation with free Tc-99m-MORF and significantly higher with the antisense than with the sense MORF. In mice, tumor and normal-tissue accumulations of the Tc-99m-MORF/tat/trastuzumab nanoparticle were comparable to those of free Tc-99m-trastuzumab, confirming the improved pharmacokinetics due to the trastuzumab component. Although kidneys, liver, and other normal tissues also accumulated the nanoparticle, immunohistochemical evaluation of tissue sections in mice receiving the Cy3-MORF/tat/trastuzumab nanoparticle showed evidence of nuclear accumulation only in tumor tissue. In a dose escalation study, as measured by the surviving fraction, the nanoparticle significantly increased the kill of SK-BR-3 breast cancer Her2+/RI alpha+ cells, compared with all controls. Conclusion: Significant radiation-induced antisense-mediated cytotoxicity of tumor cells in vitro was achieved using an Auger electron-emitting antisense MORF oligomer administered as a member of a 3-component streptavidin-delivery nanoparticle.
What problem does this paper attempt to address?